All
Results: 16921-16932 of 78288

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics

CEOs Increasingly See Disruption as the Norm and Worry about Ability to Keep Pace with Change, According to AlixPartners’ 2026 Disruption Index







